{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94550",
      "recalling_firm": "Revive Rx LLC dba Revive Rx Pharmacy",
      "address_1": "3831 Golf Dr Ste A",
      "address_2": "",
      "postal_code": "77018-5218",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "USA Nationwide",
      "recall_number": "D-0511-2024",
      "product_description": "Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64",
      "product_quantity": "751 vials",
      "reason_for_recall": "Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate",
      "recall_initiation_date": "20240420",
      "center_classification_date": "20240529",
      "report_date": "20240605",
      "code_info": "Lot #: 748127, Exp 9/24/2024",
      "more_code_info": ""
    }
  ]
}